According to research reviewed by Gram, it is still unknown whether one long weekly workout cuts liver fat as well as three shorter sessions. A planned trial of 300 adults with central obesity and fatty liver disease will test this over 4 months.
Fatty liver disease is now the most common liver condition in the world, and exercise is one of the main ways doctors suggest managing it. Many people find it hard to fit exercise into a busy week, so a key question is whether one longer weekly workout works as well as three shorter ones. According to research reviewed by Gram, this question has not been answered yet. A newly published study protocol describes a planned trial of 300 adults with excess belly fat and fatty liver disease. Participants will be split into three groups: one doing a single 75-minute treadmill session per week, one doing three 25-minute sessions, and a control group taking health education classes. Liver fat will be measured with a special MRI scan. The results are not yet available, so no conclusions can be drawn at this stage.
Key Statistics
A 2026 randomized controlled trial protocol published in Contemporary Clinical Trials plans to enroll 300 adults with central obesity and fatty liver disease to compare different weekly exercise schedules.
The planned trial will ask one exercise group to complete 75 minutes of vigorous treadmill training in a single weekly session, while another group will split the same 75 minutes into three 25-minute sessions.
Liver fat will be measured with proton magnetic resonance spectroscopy at baseline, at 4 months after the program ends, and again at 10 months to check whether any changes last.
The Quick Take
- What they studied: Researchers want to know whether exercising once a week for a longer session reduces liver fat as well as exercising three times a week for shorter sessions, when the total weekly exercise time is the same.
- Who participated: The trial plans to enroll 300 adults who have excess fat around the waist, known as central obesity, and fatty liver disease. No participant results have been reported yet because this is a study plan, not a finished study.
- Key finding: This is a study protocol, which is a detailed plan written before the research begins. It does not contain results. The planned trial will measure how much liver fat changes after 4 months of exercise and again at 10 months.
- What it means for you: No new advice can be drawn from this plan alone. Current guidelines already recommend regular aerobic activity for liver health, and the total weekly amount of exercise is what matters most. Talk with your doctor before starting a new exercise program, especially if you have liver disease.
The Research Details
This is a randomized controlled trial, which is one of the most reliable ways to test whether a treatment works. Participants will be assigned by chance to one of three groups, so the groups should be similar at the start. This approach helps separate the effects of exercise from other factors.
The two exercise groups will follow World Health Organization guidelines by completing 75 minutes of hard treadmill exercise each week. One group will do this in a single session, while the other will split it into three sessions of 25 minutes. The control group will attend a 150-minute health education class every two weeks instead of exercising.
The main measurement is the amount of fat stored inside liver cells, measured with a scan called proton magnetic resonance spectroscopy. Measurements will be taken at the start, at the end of the 4-month program, and again 6 months later to see whether any changes last.
Randomly assigning people to groups helps prevent guesswork about who benefits from exercise. Measuring liver fat with a precise scan, rather than relying only on weight or self-reports, gives a more direct view of the liver. Including a follow-up check at 10 months also shows whether any benefit lasts after supervised exercise stops.
The trial is planned to be assessor-blinded, meaning the people who measure outcomes will not know which group each participant is in. This reduces bias in the results. Because the study is run at a single center, its findings may need to be confirmed in other locations and populations. As a protocol, its quality will only be judged once the full results are published.
What the Results Show
No results are available yet, because this document describes a plan for a trial rather than a completed study. The main outcome will be the change in liver fat measured by MRI spectroscopy after 4 months of exercise.
The researchers plan to compare the two exercise groups with each other and with the control group. This comparison will show whether a single weekly session produces similar liver fat reductions to three shorter sessions, or whether one approach works better.
Because the total exercise time is matched across the two exercise groups, any difference between them should reflect how the exercise is spread out during the week rather than how much exercise was done.
The study also plans to look at liver fat again at 10 months, which will show whether improvements last after the supervised program ends. The trial may also track other health markers, though these details are not described in the protocol abstract.
If the trial finds that one weekly session works as well as three, it could make exercise easier for people with busy schedules. This would matter for a condition that affects a large share of adults worldwide.
Previous research has generally found that regular aerobic exercise can reduce liver fat, even without weight loss. Most studies, however, have used structured programs of several sessions each week. This trial asks a more practical question about whether the same total exercise can be done in fewer, longer sessions, which has not been well studied in this group of patients.
Because this is a protocol, no conclusions can be drawn yet about whether either exercise schedule works. The trial is planned at a single center, so results may not apply equally to all groups of people or healthcare settings. Supervised treadmill training may not reflect the exercise people would do on their own at home. The study also runs for only 4 months of exercise, so it may not show what happens over many years.
The Bottom Line
Current evidence supports regular aerobic exercise as part of managing fatty liver disease, with the total weekly amount of activity being the most important factor. Whether one weekly session works as well as three remains unknown, and confidence in any recommendation on this point is currently low until the trial results are published.
People with fatty liver disease, excess belly fat, or those who struggle to exercise several times a week may find this research especially relevant once results are available. Clinicians who advise patients on exercise may also want to follow the findings. People without liver disease should follow general exercise guidelines, since this trial does not yet provide new advice for them.
The exercise program in the planned trial lasts 4 months, with a follow-up at 10 months. Results will not be available until the trial is completed and published, so no practical changes should be expected from this study alone in the near term.
Frequently Asked Questions
Can I get the same liver health benefits from exercising only once a week?
This question is not yet answered by research. A planned trial of 300 adults will compare one weekly 75-minute session with three 25-minute sessions. Until results are published, current guidelines focus on total weekly exercise, so talk with your doctor about the best plan for you.
How much exercise is recommended for fatty liver disease?
Health guidelines generally recommend 150 minutes of moderate aerobic activity or 75 minutes of vigorous activity each week. Exercise can help reduce liver fat, and a planned 2026 trial of 300 adults will examine whether the weekly schedule changes the results.
What is the best way to measure liver fat in a research study?
Researchers in this planned trial will use proton magnetic resonance spectroscopy, an MRI-based scan that measures fat stored inside liver cells. The scan will be taken at baseline, after the 4-month program, and at a 10-month follow-up to track changes over time.
What is MASLD, and how is it different from fatty liver disease?
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is the newer name for a condition that causes fat buildup in the liver. It is now considered the most common liver disease worldwide. It is closely linked to excess belly fat, high blood sugar, and high blood pressure.
Want to Apply This Research?
- Log the total minutes of brisk or vigorous aerobic activity each week, aiming for at least 150 minutes of moderate activity or 75 minutes of vigorous activity, as recommended by health guidelines. Track whether sessions are spread across several days or completed in one or two longer sessions.
- Encourage users to schedule their weekly exercise in the way that fits their life best, whether that is short sessions on several days or one longer session on a weekend. Remind users to speak with a doctor before starting a new program if they have a liver condition.
- Over the long term, users can track weekly exercise totals, waist measurements, and any check-up results their doctor shares, such as liver enzyme tests. Review these trends every few months and update the plan if progress stalls, with medical guidance.
This article describes a research plan, not completed results, and it is for general information only. It is not medical advice. Anyone with fatty liver disease or other liver conditions should speak with a qualified healthcare provider before changing their exercise routine or treatment plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.